Purpose: To demonstrate the effect of intravitreal bevacizumab (IVB) on the size and vascularity of the fibro-vascular complex with the optical coherence tomography angiography (OCTA) before pars plana vitrectomy (PPV).
Methods: Observational case series of three eyes with active diabetic fibro-vascular complex and tractional retinal detachment (TRD) who underwent IVB (1.25 mg/0.05 ml) two days before proceeding to PPV. OCTA was carried out prior to IVB, two days after IVB and six weeks after PPV.
Results: OCTA showed a reduction in the size and calibre of the diabetic fibro-vascular complex two days after IVB in all the cases. Consequently, there was less traumatic dissection of the fibro-vascular membranes during PPV and thus reduced chances of intraoperative and postoperative vitreous cavity bleeding. One case showed mild hemorrhage in the posterior vitreous on the second day post-injection which implies the increased traction caused by IVB.
Conclusions: In this case series, we have used OCTA to demonstrate how IVB is highly effective in reducing the vascularity of diabetic fibro-vascular membranes. This finding also suggests that the use of IVB before PPV in the management of diabetic TRD could also be much shorter than the advocated standard practice of one week in most institutions.
Keywords: Bevacizumab; Diabetic tractional retinal detachment; OCTA; Vitreous hemorrhage.
Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.Ophthalmology. 2009 May;116(5):927-38. doi: 10.1016/j.ophtha.2008.11.005. Epub 2009 Mar 9. Ophthalmology. 2009. PMID: 19269033
Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial.Am J Ophthalmol. 2019 Nov;207:279-287. doi: 10.1016/j.ajo.2019.05.007. Epub 2019 May 13. Am J Ophthalmol. 2019. PMID: 31095954 Clinical Trial.
Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):641-50. doi: 10.1007/s00417-009-1247-7. Epub 2009 Dec 12. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20012643
Surgical management of retinal diseases: proliferative diabetic retinopathy and traction retinal detachment.Dev Ophthalmol. 2014;54:196-203. doi: 10.1159/000360467. Epub 2014 Aug 26. Dev Ophthalmol. 2014. PMID: 25196770 Review.
A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy.Br J Ophthalmol. 2011 Sep;95(9):1216-22. doi: 10.1136/bjo.2010.189514. Epub 2011 Jan 27. Br J Ophthalmol. 2011. PMID: 21278146 Free PMC article. Review.
- Rice T.A., Michels R.G., Rice E.F. Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol. 1983;95(1):22–33. - PubMed
- Ho T., Smiddy W.E., Flynn H.W. Vitrectomy in the management of diabetic eye disease. Surv Ophthalmol. 1992;37(3):190–202. - PubMed
- Blankenship G.W. Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. Ophthalmology. 1986;93(1):39–44. - PubMed
- Yorston D., Wickham L., Benson S., Bunce C., Sheard R., Charteris D. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92(3):365–368. - PubMed
- Novak M.A., Rice T.A., Michels R.G., Auer C. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology. 1984;91(12):1485–1489. - PubMed